|
US3164603A
(en)
|
|
1965-01-05 |
|
xnhcox |
|
DE1108698B
(de)
|
1959-09-03 |
1961-06-15 |
Hoechst Ag |
Verfahren zur Herstellung von 2-(2'-Aminoaryl)-4, 5-arylen-1, 2, 3-triazolen
|
|
FR1439129A
(fr)
|
1965-04-02 |
1966-05-20 |
Chimetron |
Nouveaux sulfonylbenzimidazoles
|
|
FR1476529A
(fr)
|
1965-04-24 |
1967-04-14 |
Chimetron Sarl |
Nouveaux dérivés benzimidazole-sulfoniques et sulfamides correspondants
|
|
US3503929A
(en)
|
1965-10-21 |
1970-03-31 |
Minnesota Mining & Mfg |
Polyimidazoquinazolines and polyamidobenzimidazoles
|
|
US3517007A
(en)
|
1968-04-05 |
1970-06-23 |
American Home Prod |
5 - acetamido - 4 - pyrimidinecarboxamides,5 - acetamido - 4 - pyrimidinecarboxylic acid hydrazides and related compounds
|
|
US3928228A
(en)
|
1969-04-28 |
1975-12-23 |
Sterling Drug Inc |
4,4{40 -Stilbenebis-pyridooxazoles and related optical brighteners and polymeric compositions brightened thereby
|
|
US3712888A
(en)
|
1970-12-14 |
1973-01-23 |
American Cyanamid Co |
Bis-pyridoxazole-stilbene derivatives for optical brightening
|
|
CA1006165A
(en)
|
1971-04-06 |
1977-03-01 |
Eastman Kodak Company |
Ballasted color photographic couplers
|
|
AR208500A1
(es)
|
1972-06-14 |
1977-02-15 |
Merck & Co Inc |
Procedimiento para la preparacion de derivados de oxazolo(4,5-b)-piridinas
|
|
US4038396A
(en)
|
1975-02-24 |
1977-07-26 |
Merck & Co., Inc. |
Anti-inflammatory oxazole[4,5-b]pyridines
|
|
PL96241B1
(pl)
|
1975-06-30 |
1977-12-31 |
|
Sposob wytwarzania 2-/2-podstawionych-4-tiazolilo/-benzimidazoli
|
|
JPS6040016B2
(ja)
|
1977-08-31 |
1985-09-09 |
コニカ株式会社 |
マゼンタ色素画像の形成方法
|
|
US4471040A
(en)
|
1980-09-10 |
1984-09-11 |
Canon Kabushiki Kaisha |
Electrophotographic disazo photosensitive member
|
|
US4727064A
(en)
|
1984-04-25 |
1988-02-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Pharmaceutical preparations containing cyclodextrin derivatives
|
|
US4939133A
(en)
|
1985-10-01 |
1990-07-03 |
Warner-Lambert Company |
N-substituted-2-hydroxy-α-oxo-benzeneacetamides and pharmaceutical compositions having activity as modulators of the arachidonic acid cascade
|
|
DE3807084A1
(de)
|
1988-03-04 |
1989-09-14 |
Knoll Ag |
Neue benzimidazo(1,2-c)chinazoline, ihre herstellung und verwendung
|
|
JPH04190232A
(ja)
|
1990-11-26 |
1992-07-08 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラー写真感光材料
|
|
US5814651A
(en)
|
1992-12-02 |
1998-09-29 |
Pfizer Inc. |
Catechol diethers as selective PDEIV inhibitors
|
|
JPH06247969A
(ja)
|
1992-12-28 |
1994-09-06 |
Takeda Chem Ind Ltd |
縮合複素環化合物及びそれを含む農園芸用殺虫剤
|
|
US5852011A
(en)
|
1994-05-31 |
1998-12-22 |
Mitsui Chemicals, Inc. |
Benzimidazole derivatives
|
|
AUPN449295A0
(en)
|
1995-07-28 |
1995-08-24 |
Inner And Eastern Health Care Network, The |
Radioprotectors
|
|
WO1997012613A1
(en)
|
1995-10-05 |
1997-04-10 |
Warner-Lambert Company |
Method for treating and preventing inflammation and atherosclerosis
|
|
US5808087A
(en)
|
1995-11-29 |
1998-09-15 |
Mitsui Chemicals, Inc. |
Sulfonium salts of pyrrolylbenzimidazoles
|
|
JP2002509858A
(ja)
|
1997-12-31 |
2002-04-02 |
ルトガーズ，ザ ステイト ユニバーシティ オブ ニュージャージー |
複素環式トポイソメラーゼ毒化合物
|
|
US6653309B1
(en)
|
1999-04-26 |
2003-11-25 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of IMPDH enzyme technical field of the invention
|
|
ATE306481T1
(de)
|
1999-05-12 |
2005-10-15 |
Ortho Mcneil Pharm Inc |
Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
|
|
SI1194425T1
(sl)
|
1999-06-23 |
2005-12-31 |
Sanofi Aventis Deutschland |
Substituirani benzimidazoli
|
|
WO2001021615A1
(fr)
|
1999-09-17 |
2001-03-29 |
Yamanouchi Pharmaceutical Co., Ltd. |
Dérivés de benzimidazole
|
|
DE19948434A1
(de)
|
1999-10-08 |
2001-06-07 |
Gruenenthal Gmbh |
Substanzbibliothek enthaltend bicyclische Imidazo-5-amine und/oder bicyclische Imidazo-3-amine
|
|
JP2004503553A
(ja)
|
2000-06-14 |
2004-02-05 |
ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー |
６，５−縮合二環式複素環
|
|
US6448281B1
(en)
|
2000-07-06 |
2002-09-10 |
Boehringer Ingelheim (Canada) Ltd. |
Viral polymerase inhibitors
|
|
JP2002161084A
(ja)
|
2000-11-28 |
2002-06-04 |
Sumitomo Pharmaceut Co Ltd |
複素環誘導体
|
|
US20040010033A1
(en)
|
2001-02-20 |
2004-01-15 |
Pfizer Inc. |
Non-peptide GnRH agents, methods and intermediates for their preparation
|
|
WO2002066454A1
(fr)
|
2001-02-21 |
2002-08-29 |
Sankyo Company, Limited |
Derives de chromene
|
|
CN1514833A
(zh)
|
2001-03-28 |
2004-07-21 |
����˹�ж�-����˹˹������˾ |
新型酪氨酸激酶抑制剂
|
|
US7081454B2
(en)
|
2001-03-28 |
2006-07-25 |
Bristol-Myers Squibb Co. |
Tyrosine kinase inhibitors
|
|
WO2003007959A1
(en)
|
2001-07-16 |
2003-01-30 |
Fujisawa Pharmaceutical Co., Ltd. |
Quinoxaline derivatives which have parp inhibitory action
|
|
JP4658473B2
(ja)
|
2001-07-27 |
2011-03-23 |
キュリス，インコーポレイテッド |
ヘッジホッグシグナル伝達経路メディエーター、それに関連した組成物及び利用
|
|
CA2458926A1
(en)
|
2001-09-13 |
2003-03-13 |
Genesoft Pharmaceuticals, Inc. |
Methods of treating infection by drug resistant bacteria
|
|
US6897208B2
(en)
|
2001-10-26 |
2005-05-24 |
Aventis Pharmaceuticals Inc. |
Benzimidazoles
|
|
AU2002349477A1
(en)
|
2001-11-26 |
2003-06-10 |
Takeda Chemical Industries, Ltd. |
Bicyclic derivative, process for producing the same, and use
|
|
WO2003048140A1
(en)
|
2001-12-03 |
2003-06-12 |
Japan Tobacco Inc. |
Azole compound and medicinal use thereof
|
|
EP1472245A2
(en)
|
2002-02-06 |
2004-11-03 |
Vertex Pharmaceuticals Incorporated |
Heteroaryl compounds useful as inhibitors of gsk-3
|
|
GB0205256D0
(en)
|
2002-03-06 |
2002-04-17 |
Oxford Glycosciences Uk Ltd |
Novel compounds
|
|
US7144896B2
(en)
|
2002-03-18 |
2006-12-05 |
Merck Frosst Canada Ltd. |
Hetero-bridge substituted 8-arylquinoline pde4 inhibitors
|
|
CA2479338A1
(en)
|
2002-03-20 |
2003-10-02 |
Metabolex, Inc. |
Substituted phenylacetic acids
|
|
TW200304820A
(en)
|
2002-03-25 |
2003-10-16 |
Avanir Pharmaceuticals |
Use of benzimidazole analogs in the treatment of cell proliferation
|
|
JP4224979B2
(ja)
|
2002-04-09 |
2009-02-18 |
大正製薬株式会社 |
インターロイキン１２抑制剤
|
|
JP4239463B2
(ja)
|
2002-04-09 |
2009-03-18 |
大正製薬株式会社 |
３−トリフルオロメチルアニリド誘導体
|
|
NZ535764A
(en)
|
2002-04-18 |
2007-10-26 |
Schering Corp |
1-(4-piperidinyl) benzimidazolones as histamine H3 antagonists
|
|
JP2003313176A
(ja)
|
2002-04-24 |
2003-11-06 |
Sankyo Co Ltd |
アミノアゾール誘導体
|
|
RS20050019A
(sr)
|
2002-07-12 |
2007-09-21 |
Sanofi - Aventis Pharma Deutschland Gmbh., |
Heterociklično supstituisani benzoilkarbamidi,postupak za njihovu proizvodnju i njihova primena kao leka
|
|
SE0202429D0
(sv)
|
2002-08-14 |
2002-08-14 |
Astrazeneca Ab |
Novel Compounds
|
|
DE10237722A1
(de)
|
2002-08-17 |
2004-08-19 |
Aventis Pharma Deutschland Gmbh |
Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase
|
|
JP2004075614A
(ja)
|
2002-08-20 |
2004-03-11 |
Sankyo Co Ltd |
クロメン誘導体を含有する医薬
|
|
TW200501960A
(en)
|
2002-10-02 |
2005-01-16 |
Bristol Myers Squibb Co |
Synergistic kits and compositions for treating cancer
|
|
EP1562605A4
(en)
|
2002-10-08 |
2006-07-12 |
Massachusetts Inst Technology |
COMPOUNDS FOR MODULATING CHOLESTER INTRANSPORT
|
|
WO2004033434A1
(en)
|
2002-10-09 |
2004-04-22 |
Pfizer Products Inc. |
Pyrazole compounds for treatment of neurodegenerative disorders
|
|
US8252520B2
(en)
|
2002-10-11 |
2012-08-28 |
Taivex Therapeutics Corporation |
Methods and compounds for inhibiting Hec1 activity for the treatment of proliferative diseases
|
|
EP1562931A2
(en)
|
2002-10-25 |
2005-08-17 |
Genesoft Pharmaceuticals, Inc. |
Anti-infective biaryl compounds
|
|
EP1581217A4
(en)
|
2002-11-01 |
2007-07-11 |
Merck & Co Inc |
CARBONYLAMINO-BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF ANDROGENIC RECEPTORS
|
|
AU2003302497A1
(en)
|
2002-11-27 |
2004-06-23 |
Ph. D. Edward M. Eddy |
Glyceraldehyde 3-phosphate dehydrogenase-s(gapds), a glycolytic enzyme expressed only in male germ cells,is a target for male contraception
|
|
DE10300398A1
(de)
|
2003-01-09 |
2004-07-22 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verwendung von substituierten 2-Phenylbenzimidazolen als Arzneimittel
|
|
US7329678B2
(en)
|
2003-01-28 |
2008-02-12 |
Smithkline Beecham Corporation |
Chemical compounds
|
|
US7265138B2
(en)
|
2003-02-10 |
2007-09-04 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
|
US7157460B2
(en)
|
2003-02-20 |
2007-01-02 |
Sugen Inc. |
Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors
|
|
CA2517256C
(en)
|
2003-02-26 |
2013-04-30 |
Sugen, Inc. |
Aminoheteroaryl compounds as protein kinase inhibitors
|
|
CA2517720A1
(en)
|
2003-03-11 |
2004-09-23 |
Pfizer Products Inc. |
Pyrazine compounds as transforming growth factor (tgf) inhibitors
|
|
JP2006520794A
(ja)
|
2003-03-21 |
2006-09-14 |
スミスクライン ビーチャム コーポレーション |
化合物
|
|
TWI372050B
(en)
|
2003-07-03 |
2012-09-11 |
Astex Therapeutics Ltd |
(morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
|
|
GB2405793A
(en)
|
2003-09-12 |
2005-03-16 |
4 Aza Bioscience Nv |
Pteridine derivatives for treating TNF-alpha related disorders
|
|
WO2005025574A2
(en)
|
2003-09-12 |
2005-03-24 |
4 Aza Bioscience Nv |
PTERIDINE DERIVATIVES FOR THE TREATMENT OF SEPTIC SHOCK AND TNF-α-RELATED DISEASES.
|
|
BRPI0414266A
(pt)
|
2003-09-19 |
2006-11-07 |
Hoffmann La Roche |
derivados de tiazolopiridina como ligandos receptores da adenosina
|
|
JP4795634B2
(ja)
|
2003-10-31 |
2011-10-19 |
出光興産株式会社 |
有機薄膜トランジスタ
|
|
JP2005162855A
(ja)
|
2003-12-02 |
2005-06-23 |
Konica Minolta Holdings Inc |
着色組成物、インクジェット記録用インク、カラートナー、光記録媒体、感熱転写記録材料用インクシート、カラーフィルター、及び該インクジェット記録用インクを用いたインクジェット記録方法
|
|
EP1723138B1
(en)
|
2004-02-11 |
2010-07-14 |
Basilea Pharmaceutica AG |
Substituted benzimidazoles and their use for inducing apoptosis
|
|
EP1730134A1
(en)
|
2004-03-26 |
2006-12-13 |
Vertex Pharmaceuticals Incorporated |
Pyridine inhibitors of erk2 and uses thereof
|
|
DE102004021716A1
(de)
|
2004-04-30 |
2005-12-01 |
Grünenthal GmbH |
Substituierte Imidazo[1,2-a]pyridin-Verbindungen und Arzneimittel enthaltend substituierte Imidazo[1,2-a]pyridin-Verbindungen
|
|
TW200600492A
(en)
|
2004-05-18 |
2006-01-01 |
Achillion Pharmaceuticals Inc |
Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
|
|
RS56037B1
(sr)
|
2004-06-24 |
2017-09-29 |
Vertex Pharma |
Modulatori atp-vezujućih kasetnih transportera
|
|
SG155222A1
(en)
|
2004-08-13 |
2009-09-30 |
Genentech Inc |
Thiazole based inhibitors of atp-utilizing enzymes
|
|
DE102004039789A1
(de)
|
2004-08-16 |
2006-03-02 |
Sanofi-Aventis Deutschland Gmbh |
Arylsubstituierte polycyclische Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
GB0421525D0
(en)
|
2004-09-28 |
2004-10-27 |
Novartis Ag |
Inhibitors of protein kineses
|
|
EP1807074B1
(en)
|
2004-11-03 |
2013-10-23 |
Curis, Inc. |
Mediators of hedgehog signaling pathways, compositions and uses related thereto
|
|
EP1819341A4
(en)
|
2004-11-10 |
2011-06-29 |
Synta Pharmaceuticals Corp |
IL-12 MODULATORY CONNECTIONS
|
|
WO2006094237A2
(en)
|
2005-03-03 |
2006-09-08 |
Sirtris Pharmaceuticals, Inc. |
Acridine and quinoline dervatives as sirtuin modulators
|
|
JP2008535790A
(ja)
*
|
2005-03-03 |
2008-09-04 |
サートリス ファーマシューティカルズ， インコーポレイテッド |
サーチュインモジュレーターであるｎ−フェニルベンズアミド誘導体
|
|
WO2006113458A1
(en)
|
2005-04-15 |
2006-10-26 |
Bristol-Myers Squibb Company |
Heterocyclic inhibitors of protein arginine methyl transferases
|
|
US8093401B2
(en)
|
2005-08-04 |
2012-01-10 |
Sirtris Pharmaceuticals, Inc. |
Sirtuin modulating compounds
|
|
EP1910385B1
(en)
*
|
2005-08-04 |
2013-07-24 |
Sirtris Pharmaceuticals, Inc. |
Benzothiazoles and thiazolopyridines as sirtuin modulators
|
|
US8088928B2
(en)
|
2005-08-04 |
2012-01-03 |
Sirtris Pharmaceuticals, Inc. |
Sirtuin modulating compounds
|
|
CN101282974A
(zh)
*
|
2005-08-04 |
2008-10-08 |
西特里斯药业公司 |
作为sirtuin调节剂的咪唑并吡啶衍生物
|
|
US7855289B2
(en)
|
2005-08-04 |
2010-12-21 |
Sirtris Pharmaceuticals, Inc. |
Sirtuin modulating compounds
|
|
JP4396777B2
(ja)
|
2006-07-14 |
2010-01-13 |
東洋インキ製造株式会社 |
ポリエステル分散剤とその製造方法、及びそれを用いた顔料組成物
|
|
WO2008073451A2
(en)
|
2006-12-11 |
2008-06-19 |
Sirtris Pharmaceuticals, Inc. |
Benzoimidazole derivatives as sirtuin (sir) modulating compounds
|
|
MX2009009304A
(es)
|
2007-03-01 |
2009-11-18 |
Novartis Ag |
Inhibidores de cinasa pim y metodos para su uso.
|
|
CL2008001821A1
(es)
|
2007-06-20 |
2009-03-13 |
Sirtris Pharmaceuticals Inc |
Compuestos derivados de imidazo[2,1-b]-tiazol; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de diabetes, sindrome metabolico, resistencia a la insulina, entre otras.
|
|
TW200916472A
(en)
|
2007-06-20 |
2009-04-16 |
Sirtris Pharmaceuticals Inc |
Sirtuin modulating compounds
|
|
JP2011502984A
(ja)
|
2007-11-01 |
2011-01-27 |
サートリス ファーマシューティカルズ， インコーポレイテッド |
サーチュインモジュレーターとしてのアミド誘導体
|
|
CA2705138A1
(en)
*
|
2007-11-08 |
2009-05-14 |
Sirtris Pharmaceuticals, Inc. |
Solubilized thiazolopyridines
|
|
US20100168084A1
(en)
|
2008-05-08 |
2010-07-01 |
Huber L Julie |
Therapeutic compounds and related methods of use
|
|
CN102177157A
(zh)
|
2008-08-12 |
2011-09-07 |
西特里斯药业公司 |
作为沉默调节蛋白调节剂的苯并*唑类、苯并噻唑类和相关的类似物
|